Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-018-2714-5
Abstract: BackgroundPatients with non-small cell lung cancer (NSCLC) and a prior or synchronous second malignancy are generally excluded from clinical trials. Therefore, little is known on prevalence and prognosis of these patients.Methods1252 patients diagnosed with NSCLC… read more here.
Keywords: malignancy; nsclc; second malignancy; lung cancer ... See more keywords
MP11-18 ORIGIN OF A SECOND MALIGNANCY HARBORING ISOCHROMOSOME 12P IN PATIENTS WITH HISTORY OF TESTICULAR GERM CELL TUMOR (TGCT)
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000831.018
Abstract: INTRODUCTION AND OBJECTIVE:The cumulative incidence of subsequent solid malignant neoplasm (SMN) after treatment of TGCT is about 10% over a 25-year period. Isochromosome 12p has been used to defin... read more here.
Keywords: mp11 origin; origin second; isochromosome 12p; second malignancy ... See more keywords
Second malignancy versus recurrence after complete resection of thymoma
Sign Up to like & getrecommendations! Published in 2018 at "Asian Cardiovascular and Thoracic Annals"
DOI: 10.1177/0218492318765872
Abstract: Background Patients undergoing complete resection of thymoma occasionally develop a recurrence of thymoma; they are also at risk of developing a second malignancy. The objective of our study was to compare the incidence and mortality… read more here.
Keywords: recurrence; complete resection; second malignancy; resection thymoma ... See more keywords